Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-07-13 Purchase | 2023-07-17 8:00 pm | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 1,750,000 | $17 | $29,750,000 | 1,797,758 (Indirect Direct) | View |
2023-07-13 Purchase | 2023-07-17 8:00 pm | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 2,941,176 | $17 | $49,999,992 | 988,045 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-28 Other | 2024-04-01 5:44 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director | 498,765 | $0 | 9,006,126 (Indirect) | View |
2024-01-29 Other | 2024-01-31 4:31 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 943,695 | $0 | 1,046,027 (Indirect) | View |
2023-12-18 Option Award | 2023-12-20 8:01 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 175,345 | $0 | 175,345 (Direct) | View |
2023-12-18 Option Award | 2023-12-20 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 175,345 | $0 | 175,345 (Direct) | View |
2023-12-18 Option Award | 2023-12-20 8:00 pm | N/A 2033-12-18 | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 398,512 | $0 | 398,512 (Direct) | View |
2023-08-17 Option Award | 2023-08-21 4:06 pm | N/A 2033-08-17 | Apogee Therapeutics Inc. | APGE | McKenna Mark C. Director | 150,000 | $0 | 200,000 (Direct) | View |
2023-07-13 Option Award | 2023-07-17 8:01 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Gottesdiener Andrew Director | 47,758 | $0 | 47,758 (Direct) | View |
2023-07-13 Option Award | 2023-07-17 8:00 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 47,758 | $0 | 1,797,758 (Direct) | View |
2023-07-13 Option Award | 2023-07-17 8:00 pm | N/A 2033-07-13 | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Fairmount Healthcare Co-Invest II L.P. Kiselak Tomas Harwin Peter Evan Director | 95,516 | $0 | 988,045 (Direct) | View |
Ownership(A) | 2023-07-17 5:06 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 0 | $0 | 300,788 (Direct) | View |
Ownership(A) | 2023-07-17 5:05 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 0 | $0 | 206,871 (Direct) | View |
Ownership(A) | 2023-07-17 5:04 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 0 | $0 | 1,489,487 (Direct) | View |
Ownership(A) | 2023-07-17 5:03 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director | 0 | $0 | 34,824 (Direct) | View |
Ownership(A) | 2023-07-17 4:59 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 0 | $0 | 34,824 (Direct) | View |
Ownership | 2023-07-13 6:42 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Dambkowski Carl Chief Medical Officer | 0 | $0 | 279,105 (Direct) | View |
Ownership | 2023-07-13 6:42 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Henderson Jane Chief Financial Officer | 0 | $0 | 188,286 (Direct) | View |
Ownership | 2023-07-13 6:42 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | HENDERSON MICHAEL THOMAS Chief Executive Officer | 0 | $0 | 1,404,304 (Direct) | View |
Ownership | 2023-07-13 6:41 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fox Jennifer A. Director | 0 | $0 | 30,187 (Direct) | View |
Ownership | 2023-07-13 6:40 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | JONES WILLIAM A JR Director | 0 | $0 | 30,187 (Direct) | View |
Ownership | 2023-07-13 6:39 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Shah Nimish P Director | 0 | $0 | 6,743,321 (Indirect) | View |
Ownership | 2023-07-13 6:39 pm | N/A N/A | Apogee Therapeutics Inc. | APGE | Fairmount Funds Management LLC Fairmount Healthcare Fund L.P. Fairmount Healthcare Fund II L.P. Director | 0 | $0 | 6,743,321 (Indirect) | View |